
Lunai Bioworks Inc.
LNAINASDAQHealthcare● Active
$2.37
$-0.08(-3.27%)
Market Cap$10745319
P/E Ratio—
52W High$33.52
52W Low$1.208
Lunai Bioworks Inc.(LNAI)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · LNAI · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.01B | $0.02B |
| G&A Expenses | $0.02B | $0.02B | $0.02B | $0.01B | $0.00B |
| Total Operating Expenses | $0.02B | $0.08B | $0.04B | $0.12B | $0.02B |
| Operating Income | ($0.02B) | ($0.08B) | ($0.04B) | ($0.12B) | ($0.02B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.18B) | ($0.09B) | ($0.04B) | ($0.11B) | ($0.03B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Income | ($0.18B) | ($0.09B) | ($0.04B) | ($0.11B) | ($0.03B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-86.24 | $-72.80 | $-56.80 | $-172.80 | $-45.36 |
| Wtd Avg Shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.02B) | ($0.09B) | ($0.04B) | ($0.11B) | ($0.03B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B
深入了解Lunai Bioworks Inc.
关于Lunai Bioworks Inc.(LNAI)损益表
Lunai Bioworks Inc.(LNAI)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,LNAI实现营收$0.00B,毛利润($0.00B)(毛利率—),净利润($0.18B)(净利率—)。
常见问题
LNAI · 4 问Lunai Bioworks Inc.(LNAI)2025财年营收为$0.00B,同比down—%。
LNAI revenueLNAI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09